keyword
https://read.qxmd.com/read/38623604/the-other-uterine-mesenchymal-neoplasms-recent-developments-and-emerging-entities
#1
JOURNAL ARTICLE
Jennifer A Bennett, Andre Pinto
Uterine mesenchymal neoplasms are a challenging group of tumors that often show overlapping morphologic features and immunohistochemical profiles. The increasing use of molecular testing in these tumors has enabled a better appreciation of their pathobiology, resulting in a wave of emerging neoplasms and improved characterization of ones previously considered exceptionally rare. Identification of specific molecular alterations has permitted targeted therapy options in tumors that were typically unresponsive to conventional therapies, as well as recognition that a subset can have a hereditary basis...
April 16, 2024: Advances in Anatomic Pathology
https://read.qxmd.com/read/38621503/gli1-co-amplification-in-well-differentiated-dedifferentiated-liposarcomas-clinicopathologic-and-molecular-analysis-of-92-cases
#2
JOURNAL ARTICLE
Aarti E Sharma, Mark Dickson, Samuel Singer, Meera R Hameed, Narasimhan P Agaram
BACKGROUND: GLI1 (12q13.3) amplification is identified in a subset of mesenchymal neoplasms with a distinct nested round cell/epithelioid phenotype. MDM2 and CDK4 genes are situated along the oncogenic 12q13-15 segment, amplification of which defines well-differentiated (WDLPS)/dedifferentiated liposarcoma (DDLPS). The 12q amplicon can occasionally include GLI1 - a gene in close proximity to CDK4. We hereby describe the first cohort of GLI1/MDM2/CDK4 co-amplified WD/DDLPS. MATERIALS AND METHODS: The departmental database was queried retrospectively for all cases of WD/DDLPS having undergone next generation (IMPACT) sequencing with confirmed MDM2, CDK4, and GLI1 co-amplification...
April 13, 2024: Modern Pathology
https://read.qxmd.com/read/38616844/penile-epithelioid-hemangioendothelioma-in-a-child
#3
Palak Singhai, Nitin James Peters, Aravind Sekar, Girdhar S Bora, Ujjwal Gorsi, Jai Kumar Mahajan
An 8-year-old boy initially thought to have a penile arteriovenous malformation was later diagnosed with a rare vascular sarcoma, epithelioid hemangioendothelioma (EHE). Despite challenges in diagnosis, he underwent supraselective angioembolization and partial penectomy for oncological clearance. EHE, a low-grade malignancy, requires prompt identification and treatment due to potential systemic involvement.
2024: Journal of Indian Association of Pediatric Surgeons
https://read.qxmd.com/read/38606111/case-report-primary-sarcoma-of-the-mandible-with-a-novel-slmap-braf-fusion
#4
Peng Zhou, Wei Liu, Jiaoyun Zheng, Haixia Zhang, Jiadi Luo
Primary sarcomas of the jaw are very rare tumor with unclear mechanism of tumorigenesis. Identification of genetic alterations contributes to better understanding of tumorigenesis and extension of tumor spectrum, as well as potential therapeutic targets application. Herein, we firstly report a case of primary sarcoma in the mandible with novel SLMAP-BRAF fusion. Morphologically, the tumor was composed of histiocyte-like cells, larger epithelioid cells, spindle cells and osteoclast-like giant cells with moderate atypia...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38595053/cytomorphology-of-metastatic-colonic-mxd4-nutm1-rearranged-sarcoma
#5
JOURNAL ARTICLE
Zachary Alan Wilkinson, Maria Luisa C Policarpio-Nicolas
This report describes the cytologic features of a recently described MXD4::NUTM1-rearranged colonic sarcoma metastatic to the midclavicular soft tissue. Thirteen years ago, a 65-year-old woman presented with a cecal mass and subsequent liver mass. The cecal mass was diagnosed as malignant undifferentiated spindled and epithelioid neoplasm based on morphology and lack of tumor immunoreactivity with a panel of epithelial, smooth muscle, skeletal, melanoma, hematologic, and GIST markers. The liver mass showed morphologic and immunophenotypic similarity to the epithelioid component of the patient's cecal mass, albeit devoid of the spindled component...
April 9, 2024: Diagnostic Cytopathology
https://read.qxmd.com/read/38584901/uncommon-thigh-mass-in-neurofibromatosis-type-1-unveiling-aggressive-epithelioid-sarcoma
#6
JOURNAL ARTICLE
Mohamed A Gharbi, Faten Limaiem, Khaled B Romdhane, Anis Tebourbi, Ramzi Bouzidi, Mouadh Nefiss
BACKGROUND: Patients with neurofibromatosis type I (NF1) have an increased risk of developing soft-tissue sarcomas, particularly those related to the nervous system. Epithelioid sarcoma (ES) is an exceptionally rare subtype of soft-tissue sarcoma, with limited knowledge about its clinical presentation and optimal management in NF1. This report aims to provide insights into the characteristics and outcomes of ES in NF1 patients. CASE DESCRIPTION: A 37-year-old man with a history of NF1 presented with a progressively worsening mass on his right inner thigh...
2024: European Journal of Case Reports in Internal Medicine
https://read.qxmd.com/read/38574041/cutaneous-syncytial-myoepithelioma-an-uncommon-and-distinct-variant-of-cutaneous-epithelioid-neoplasm
#7
JOURNAL ARTICLE
Nada Shaker, Robert Phelps, George Niedt, Omar P Sangueza, Julie Youngs, Scott Lauer, Dinesh Pradhan
BACKGROUND: Cutaneous syncytial myoepithelioma (CSM) is an uncommon and distinct variant of cutaneous myoepithelioma. We aim to present a case of CSM to enhance the recognition of this unique variant, encompassing its clinical characteristics, histopathological features, immunohistochemical staining, and therapeutic approaches. CASE PRESENTATION: A 10-year-old girl presented with a dome-shaped nodule located on the skin of her left medial distal arm. Microscopic examination of the skin biopsy revealed a well-defined dermal nodular lesion, surrounded by an epidermal collarette...
April 4, 2024: American Journal of Dermatopathology
https://read.qxmd.com/read/38560304/a-rare-coexistence-of-hybrid-tumor-low-grade-fibromyxoid-sarcoma-sclerosing-epithelioid-fibrosarcoma-and-hibernoma-in-the-same-thigh-a-case-report
#8
Muhand Alkameshki, Louis-Romée Le Nail, Matthias Tallegas, Elodie Miquelestorena-Standley, Ramy Samargandi
INTRODUCTION: We encountered a unique case of a patient with two distinct tumors coexisting in the same thigh. To the best of our knowledge, this combination of tumors in the same anatomical region has not been previously described in the literature. CASE REPORT: This case report describes a 38-year-old Caucasian male with a painless mass in his right thigh, which was later diagnosed as a hybrid tumor composed of low-grade fibromyxoid sarcoma and sclerosing epithelioid fibrosarcoma, as well as a second tumor, which was diagnosed as a hibernoma...
March 2024: Journal of Orthopaedic Case Reports
https://read.qxmd.com/read/38553308/sclerosing-epithelioid-fibrosarcoma-of-the-jaw-a-case-report-and-literature-review
#9
Samir Amer, Ahmed Lazim, Robert W Berstecher, Riya Kuklani
INTRODUCTION: Sclerosing epithelioid fibrosarcoma (SEF) is an extremely rare form of bone and soft tissue sarcoma. It occurs mainly in the deep soft tissue of the lower extremities, with few cases reported in the head and neck region. Tumors involving the oral and maxillofacial region (OMFR) and intraosseous examples are rare. CASE PRESENTATION: We present a 52-year-old male with a radiolucent lesion at the apex of the left mandibular second molar tooth with the clinical impression of a periapical granuloma...
March 6, 2024: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
https://read.qxmd.com/read/38520556/pharmacology-and-pharmacokinetics-of-tazemetostat
#10
JOURNAL ARTICLE
Marco Orleni, Jan H Beumer
Tazemetostat, a novel oral selective inhibitor of enhancer of zeste homolog 2 (EZH2), was approved by the Food and Drug Administration (FDA) in 2020 for use in patients with advanced epithelioid sarcoma or relapsed/refractory (R/R) EZH2-mutated follicular lymphoma. These indications were approved by the FDA trough accelerated approval based on objective response rate and duration of response that resulted from phase 2 clinical trials. Tazemetostat competes with S-adenosylmethionine (SAM) cofactor to inhibit EZH2, reducing the levels of trimethylated lysine 27 of histone 3 (H3K27me3), considered as pharmacodynamic marker...
March 23, 2024: Cancer Chemotherapy and Pharmacology
https://read.qxmd.com/read/38509009/metastatic-maxillary-gingival-angiosarcoma-with-aggressive-growth-a-case-report
#11
Yasutaka Hoshimoto, Takayuki Aoki, Mebae Ichikawa, Yuuki Ishii, Yusuke Kondo, Masahiro Uchibori, Masashi Sasaki, Hiroyuki Naito, Yoshihide Ota
Angiosarcoma is a rare malignant tumor of endothelial origin. It is an aggressive neoplasm with early metastasis and poor prognosis and accounts for approximately 2% of all soft tissue sarcomas. Primary tumors arising in the oral cavity account for only 1% of all angiosarcomas. Here, we report a rare case of metastatic angiosarcoma of the gingiva originating from a primary mediastinal lesion. The patient was an 83-year-old man who presented with a maxillary interincisor tumor; it was a painless mass with rounded superficial necrosis measuring 23 mm× 17 mm on the labial side and 20 mm× 17 mm on the palatal side...
April 20, 2024: Tokai Journal of Experimental and Clinical Medicine
https://read.qxmd.com/read/38497120/primary-adrenal-epithelioid-sarcoma-proximal-type-a-case-report-and-literature-review
#12
JOURNAL ARTICLE
Daocheng Fang, Hui Li, Yuanyuan Hu
Primary adrenal epithelioid sarcoma is a rare lesion of the adrenal gland, and only seven cases have been reported in the domestic and international literature to date. We herein report a case involving a 65-year-old man with primary adrenal epithelioid sarcoma. After being admitted to the hospital with an adrenal mass found on physical examination, the patient underwent laparoscopic right adrenalectomy. Postoperative pathological findings indicated an epithelioid sarcoma (proximal type). Primary adrenal epithelioid sarcoma is a rare malignancy...
March 2024: Journal of International Medical Research
https://read.qxmd.com/read/38496764/case-report-primary-pulmonary-low-grade-fibromyxoid-sarcoma-progressing-to-dedifferentiation-probably-due-to-tp53-driver-mutation
#13
Jiawen Zhang, Haisheng Fang, Xiaomei Zhu, Chenchen Yao, Qinhe Fan, Qixing Gong
Low Grade Fibromyxoid Sarcoma (LGFMS), a rare entity characterized by bland histologic features, typically affects deep soft tissues of the trunk and lower extremities. Rare cases have been reported arising from the viscera and few demonstrating morphology of high-grade dedifferentiation. Here we report a 39-year-old Chinese woman presenting with primary lung LGFMS, which metastasized to the pancreas five years after diagnosis and then relapsed ten years later as a mediastinum mass. Microscopically, the lung and pancreatic lumps shared similar classical features of LGFMS, composed of bland spindle-shaped cells with low mitotic activity...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38482674/soft-tissue-tumours-of-the-penis-the-30-year-istituto-nazionale-tumori-di-milano-experience
#14
JOURNAL ARTICLE
Maurizio Colecchia, Giacomo Maria Pini, Giancarlo Pruneri, Nicola Nicolai, Sascia Servillo
OBJECTIVE: Small series and individual cases of penile soft tissue tumours are reported in the literature: these are rare tumours that represent less than 5% of all penile tumours. METHODS: Penile soft tissue tumours were collected from the archive of the Department of Pathology at the Istituto Nazionale dei Tumori of Milan between January 1990 and October 2021. All available medical records were retrieved and reviewed to obtain clinical information. RESULTS: Our series refers to the 30-year experience of highlighting the heterogeneity in the presentation and microscopic features of these rare sarcomas...
February 2024: Pathologica
https://read.qxmd.com/read/38480799/a-platform-independent-ai-tumor-lineage-and-site-atlas-classifier
#15
JOURNAL ARTICLE
Nicholas R Rydzewski, Yue Shi, Chenxuan Li, Matthew R Chrostek, Hamza Bakhtiar, Kyle T Helzer, Matthew L Bootsma, Tracy J Berg, Paul M Harari, John M Floberg, Grace C Blitzer, David Kosoff, Amy K Taylor, Marina N Sharifi, Menggang Yu, Joshua M Lang, Krishnan R Patel, Deborah E Citrin, Kaitlin E Sundling, Shuang G Zhao
Histopathologic diagnosis and classification of cancer plays a critical role in guiding treatment. Advances in next-generation sequencing have ushered in new complementary molecular frameworks. However, existing approaches do not independently assess both site-of-origin (e.g. prostate) and lineage (e.g. adenocarcinoma) and have minimal validation in metastatic disease, where classification is more difficult. Utilizing gradient-boosted machine learning, we developed ATLAS, a pair of separate AI Tumor Lineage and Site-of-origin models from RNA expression data on 8249 tumor samples...
March 13, 2024: Communications Biology
https://read.qxmd.com/read/38470379/pec-pro-a-new-prognostic-score-from-a-series-of-87-patients-with-localized-perivascular-epithelioid-cell-neoplasms-pecomas-treated-with-curative-intent
#16
JOURNAL ARTICLE
Justine Gantzer, Maud Toulmonde, François Severac, Ali N Chamseddine, Céline Charon-Barra, Charles Vinson, Alice Hervieu, Agathe Bourgmayer, François Bertucci, Thomas Ryckewaert, Thibaud Valentin, Nelly Firmin, Loïc Chaigneau, Emmanuelle Bompas, Philippe Follana, Nathalie Rioux-Leclercq, Pauline Soibinet-Oudot, Laurence Bozec, François Le Loarer, Noëlle Weingertner, Christine Chevreau, Florence Duffaud, Jean-Yves Blay, Jean-Emmanuel Kurtz, Patrick Schöffski, Mehdi Brahmi, Gabriel G Malouf
BACKGROUND: Perivascular epithelioid cell neoplasms (PEComas) encompass a heterogeneous family of mesenchymal tumors. Previously described clinicopathologic features aimed at distinguishing benign from malignant variants but lacked prognostic value. METHODS: This retrospective analysis examined clinicopathologic data from patients who had localized PEComa across French Sarcoma Network centers. The authors analyzed 12 clinicopathologic features in a Cox proportional hazard framework to derive a multivariate prognostic risk model for event-free survival (EFS)...
March 12, 2024: Cancer
https://read.qxmd.com/read/38469238/the-patient-perspective-on-sirolimus-for-epithelioid-hemangioendothelioma-ehe-results-of-a-community-survey-highlighting-the-importance-of-equitable-access-to-treatments
#17
JOURNAL ARTICLE
Denise Robinson, Hugh Leonard, Giacomo Giulio Baldi, William D Tap, Robin L Jones, Silvia Stacchiotti, Pan Pantziarka
BACKGROUND: Epithelioid hemangioendothelioma (EHE) is an ultra-rare, vascular sarcoma with clinical presentation ranging from an indolent to an aggressive form. Over 50% of patients present with metastatic disease, requiring systemic therapy, although no systemic therapies are specifically approved for EHE. Retrospective evidence supports the activity of mTOR inhibitors (e.g. sirolimus), although available only off-label. EHE patients and advocates are therefore working to support approval of effective treatments by collecting data on patient perspectives and experiences...
2024: Frontiers in Oncology
https://read.qxmd.com/read/38460673/intra-abdominal-epithelioid-neoplasm-with-ewsr1-creb-fusions-involving-the-kidney-a-clinicopathologic-and-molecular-characterization-with-an-emphasis-on-differential-diagnosis
#18
JOURNAL ARTICLE
Ming Zhao, Hualei Gan, Shan Zhong, Qiuyan Xia, Yanfeng Bai, Jiayun Xu, Xiaodong Teng, Jian Wang
Soft tissue neoplasms harboring fusions between EWSR1 or FUS with genes encoding CREB transcription factors family (ATF1, CREB1, and CREM) are an emerging heterogeneous group of mesenchymal tumors that differ significantly in morphology, immunophenotypes, and behavior. Recently, EWSR1/FUS::CREB fusions have been recognized to define a group of aggressive neoplasms of epithelioid morphology with multiple growth patterns and a striking predilection for mesothelial-lined cavities. These neoplasms presenting as a primary neoplasm of intra-abdominal visceral organs is rare, which could elicit a wide range of differential diagnoses due to their diverse morphologies and immunohistochemical profiles...
March 7, 2024: Modern Pathology
https://read.qxmd.com/read/38457672/diagnostically-challenging-multifocal-penile-epithelioid-hemangioma-successfully-treated-with-doxorubicin-hydrochloride
#19
JOURNAL ARTICLE
Marwa M Fawzi, Galal El Anany, Mohamed M Abdelraouf, Amira Elbendary
Epithelioid hemangioma (EH), also known as angiolymphoid hyperplasia with eosinophilia, is an unusual vascular proliferation that tends to manifest in the head and neck region. Its occurrence on the penis is rare, with only scarce reported cases in the literature. The histopathological examination of this condition poses a challenge because it shares similarities with other entities, such as epithelioid hemangioendothelioma, epithelioid angiosarcoma, cutaneous epithelioid angiomatous nodule, or Kaposi sarcoma (KS)...
March 8, 2024: American Journal of Dermatopathology
https://read.qxmd.com/read/38455747/clinical-features-treatment-strategies-and-prognosis-of-epithelioid-inflammatory-myofibroblastic-sarcoma-in-children-a-multicenter-experience
#20
JOURNAL ARTICLE
Haiyan Cheng, Yu Lin, Jin Zhu, Hong Qin, Wei Yang, Xiaofeng Chang, Jun Feng, Shen Yang, Libing Fu, Nan Zhang, Kui Shi, Jian Sun, Yan Su, Mei Jin, Shan Wang, Huanmin Wang
BACKGROUND: Inflammatory myofibroblastic tumors (IMTs) are a spectrum of tumors that range in morphology and biological behavior from benign, intermediate, to apparently malignant and epithelioid inflammatory myofibroblastic sarcoma (EIMS) is one of the malignant subtypes. This study tried to provide experience and new ideas for treating this rare disease. METHODS: This study retrospectively analyzed and followed up 12 children with EIMS admitted to Beijing Children's Hospital, Baoding Children's Hospital, and Children's Hospital of Chongqing Medical University from August 2016 to May 2022...
February 29, 2024: Translational Pediatrics
keyword
keyword
81660
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.